Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
Sehgal
V N
VN
Kumar
S
S
Jain
S
S
Bhattacharya
S N
SN
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D016903:Drug Monitoring; D006099:Granuloma / Q000473:pathology; D006644:Histiocytes / Q000473:pathology; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D015439:Leprosy, Borderline / Q000188:drug therapy* / Q000473:pathology; D015441:Leprosy, Tuberculoid / Q000188:drug therapy* / Q000473:pathology; D008214:Lymphocytes / Q000473:pathology; D008297:Male; D008911:Minocycline / Q000627:therapeutic use; D015242:Ofloxacin / Q000627:therapeutic use; D012008:Recurrence; D012293:Rifampin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D007917:Leprostatic Agents; D003622:Dapsone; D015242:Ofloxacin; D008911:Minocycline; D012293:Rifampin